4//SEC Filing
Ashton-Rickardt Philip 4
Accession 0001415889-23-003675
CIK 0001821323other
Filed
Feb 28, 7:00 PM ET
Accepted
Mar 1, 4:38 PM ET
Size
5.5 KB
Accession
0001415889-23-003675
Insider Transaction Report
Form 4
Ashton-Rickardt Philip
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2023-02-28+115,000→ 115,000 totalExercise: $1.09Exp: 2033-02-27→ Common Stock (115,000 underlying)
Footnotes (1)
- [F1]The option vests as to 25% of the underlying shares of common stock on February 28, 2024, the first anniversary of the vesting commencement date, and at a rate of 6.25% of the underlying shares thereafter on the first day of each quarter following such date until the option is fully vested.
Documents
Issuer
Sigilon Therapeutics, Inc.
CIK 0001821323
Entity typeother
Related Parties
1- filerCIK 0001866197
Filing Metadata
- Form type
- 4
- Filed
- Feb 28, 7:00 PM ET
- Accepted
- Mar 1, 4:38 PM ET
- Size
- 5.5 KB